Average Weight Loss of 60 Pounds Reported in Mounjaro Trial

safety-lane.com 07105
chiropractic-lane.com
www.shopcbd-lane
NEWARK
http://www.healthy-lane.com/

Average Weight Loss of 60 Pounds Reported in Mounjaro Trial

People at high risk of getting type 2 diabetes lost on average more than 18% of their weight when taking the weight loss drug tirzepatide, more commonly known under the brand name Mounjaro, according to clinical trial results published over the weekend.

When also including weight loss from 12 weeks of diet and exercise before starting the medication, researchers estimated that people can lose 26.6% of their body weight, which is more than 60 pounds on average, in less than 2 years. The results approach weight loss levels seen with some bariatric surgeries, and are higher than those reported in studies for other breakthrough weight loss medicines like Ozempic and Wegovy. 

SOURCES:

Nature Medicine: “Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.”

CDC: “Adult BMI Calculator.”

Eli Lilly: “Lilly’s tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks.”

via Blogger https://bit.ly/3Q960Wn